These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 14609215)

  • 1. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells.
    Roncarolo MG; Gregori S; Levings M
    Novartis Found Symp; 2003; 252():115-27; discussion 127-31, 203-10. PubMed ID: 14609215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic stimulation of naturally occurring CD4+CD25+ T cells induces strong regulatory capacity with increased donor-reactivity.
    Coenen JJ; Koenen HJ; Emmer PM; van Rijssen E; Hilbrands LB; Joosten I
    Transpl Immunol; 2007 Jun; 17(4):237-42. PubMed ID: 17493525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation.
    Zorn E
    Semin Cancer Biol; 2006 Apr; 16(2):150-9. PubMed ID: 16431128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.
    Fehérvári Z; Sakaguchi S
    Int Immunol; 2004 Dec; 16(12):1769-80. PubMed ID: 15520045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated CD4+ CD25+ T cells suppress antigen-specific CD4+ and CD8+ T cells but induce a suppressive phenotype only in CD4+ T cells.
    Dieckmann D; Plöttner H; Dotterweich S; Schuler G
    Immunology; 2005 Jul; 115(3):305-14. PubMed ID: 15946248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
    Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
    Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CD4+CD25+ regulatory T cells in viral infections.
    Vahlenkamp TW; Tompkins MB; Tompkins WA
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):219-25. PubMed ID: 16126280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease.
    Karakhanova S; Munder M; Schneider M; Bonyhadi M; Ho AD; Goerner M
    J Immunother; 2006; 29(3):336-49. PubMed ID: 16699377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
    Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
    Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S
    Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 T-regulatory cells: their role in the control of immune responses.
    Groux H
    Transplantation; 2003 May; 75(9 Suppl):8S-12S. PubMed ID: 12819483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells.
    Levings MK; Bacchetta R; Schulz U; Roncarolo MG
    Int Arch Allergy Immunol; 2002 Dec; 129(4):263-76. PubMed ID: 12483031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD4+CD25+ regulatory T cells.
    Baecher-Allan C; Viglietta V; Hafler DA
    Semin Immunol; 2004 Apr; 16(2):89-98. PubMed ID: 15036232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.